Abstract:Abstract Objectives Histopathological diagnosis of colposcopically identified cervical lesions is a critical step for the recognition of cervical cancer precursors requiring treatment. Although there have been efforts to standardize the histologic diagnosis of cervical biopsy specimens, in terms of terminology and use of biomarkers, there is no uniform approach in the pathology community. Adjunctive p16 immunohistochemistry (IHC) can highlight precancer diagnoses, with use recommendations outlined by the Lower Anogenital Squamous Terminology project. Methods We assessed the diagnostic reproducibility of cervical histopathological biopsy specimens with and without p16 staining among 2 expert pathologists. Results Interpretation of p16 IHC as positive vs negative was highly reproducible (92.5% agreement, κ = 0.85); greater variation was seen in the choice of which biopsy specimens required adjunctive p16 staining (78.0% agreement, κ = 0.43). Adjunctive p16 IHC did not significantly increase diagnostic agreement under multitiered grading systems (benign vs cervical intraepithelial neoplasia [CIN] 1/low-grade squamous intraepithelial lesion vs atypical squamous metaplasia vs CIN2/high-grade squamous intraepithelial lesion [HSIL] vs CIN3/HSIL-CIN3 vs cancer) (65.5% agreement, κ = 0.56 without p16; 70.0% agreement, κ = 0.58 with p16). However, when dichotomizing diagnoses based on clinical management (less than HSIL vs HSIL+), diagnostic agreement increased with p16 IHC (90.5% agreement, κ = 0.79 without p16; 92.0% agreement, κ = 0.84 with p16). For biopsy specimens taken from women positive for human papillomavirus (HPV) type 16, agreement was similar with or without adjunctive p16 (κ = 0.80 without p16; κ = 0.78-0.80 with p16). In contrast, p16 IHC substantially improved diagnostic agreement for cervical biopsy specimens taken from women positive for other high-risk HPV strains, producing improvements in κ from 0.03 to 0.24. Conclusions Adjunctive p16 immunostaining provides useful information in the evaluation of cervical biopsies for precancer. In our study, we have demonstrated that it is highly reproducible between 2 pathologists, although the decision of which biopsies warrant its use is less so. Furthermore, although p16 IHC showed a limited increase in diagnostic reproducibility for all biopsies included in our study, it did demonstrate a more sizable gain in biopsies negative for HPV 16 but positive for other high-risk genotypes. Further studies are needed to clarify the role of p16 IHC and how it can be optimized for the detection of cervical precancer, particularly in HPV-vaccinated populations where types other than HPV 16 are relatively more important.

Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions

Relationship of P16 and Ki67 in Recurrence of HPV Infection and Cervical Intraepithelial Neoplasia.

Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix and p16, C-myc and PIK3CA Proteins—A Single-center Retrospective Study

[Evaluation of P16(INK4α) Expression in Thinprep Cervical Specimens for the Predication of High-Grade Cervical Intraepithelial Neoplasia].

Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion

Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry

The Effect of P16/ki-67 and P16/mcm2 on the Detection of Cervical Intraepithelial Neoplasia: a Prospective Study from China

P16/Ki-67 Co-Expression Associates High Risk Human Papillomavirus Persistence and Cervical Histopathology: A 3-Year Cohort Study in China

[Significance of P16/ki-67 Double Immunocytochemical Staining in Cervical Cytology ASCUS, LSIL, and ASC-H].

Evaluation of Cervical High-Grade Squamous Intraepithelial Lesions-Correlated Markers as Triage Strategy for Colposcopy After Co-Testing

Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions

Significance of High-risk Human Papillomavirus(HPV) Detection and p16~(INK4A) Protein Expression in Predicting Residual Disease or Recurrence After Cervical Conization for Cervical Intraepithelial Neoplasia

Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer

P16ink4a and Ki-67 Measurement Predict Progression of Cervical Low-Grade Squamous Intraepithelial Lesion.

Evaluation of P16/ki67 Dual Staining Compared with High-Risk HPV Testing to Assess Liquid-Based Cytology with Atypical Squamous Cells of Unknown Significance

Application of p16/Ki-67 dual-staining cytology in cervical cancers

p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.

Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study

Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women

[The role of HPV genotyping testing in follow-up of high grade squamous intraepithelial lesion after treatment].

Expression of p16 and Ki67 in laryngeal squamous cell carcinoma and their clinical significance